![Stephen L. Bandak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen L. Bandak
Direttore/Membro del Consiglio presso
Hapten Sciences, Inc.
Profilo
Stephen L.
Bandak is currently the Director at Hapten Sciences, Inc. and a Member of The Royal College of Physicians since 1977.
He was previously the Vice President-Medical & Regulatory Affairs at Novavax, Inc. and the Chief Medical Officer at Synosia Therapeutics AG from 2007 to 2011, at Biotie Therapies Oy from 2011 to 2016, and at Synosia Therapeutics, Inc. from 2007 to 2011.
Posizioni attive di Stephen L. Bandak
| Società | Posizione | Inizio |
|---|---|---|
Hapten Sciences, Inc.
 Hapten Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures molecule products | Direttore/Membro del Consiglio | - |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1977 |
Precedenti posizioni note di Stephen L. Bandak
| Società | Posizione | Fine |
|---|---|---|
| BIOTIE THERAPIES CORP | Direttore Tecnico/Scientifico/R&S | 30/06/2016 |
Synosia Therapeutics AG
 Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of psychiatry and neurology diseases | Direttore Tecnico/Scientifico/R&S | 01/01/2011 |
Synosia Therapeutics, Inc.
 Synosia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops products for unmet medical needs in psychiatry and neurology | Direttore Tecnico/Scientifico/R&S | 01/01/2011 |
| NOVAVAX, INC. | Direttore Tecnico/Scientifico/R&S | 19/09/2011 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
77
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Synosia Therapeutics AG
Synosia Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of psychiatry and neurology diseases | Health Technology |
Hapten Sciences, Inc.
Hapten Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures molecule products | Health Technology |
Biotie Therapies Oy
 Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synosia Therapeutics, Inc.
Synosia Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops products for unmet medical needs in psychiatry and neurology | Health Technology |
